国外亚洲成av人片在线观看,欧美性受

熱門搜索化學(xué)品最多只顯示前20條，請(qǐng)點(diǎn)擊“搜索化學(xué)品”查看所有結(jié)果

CAS登錄號(hào)

中文名

英文名

分子結(jié)構(gòu)式

分子式

詳情

供應(yīng)商

136553-76-9

Cyclo(D-a-glutamyl-L-prolyl-D-valyl-L-leucyl-D-tryptophyl);
1H-Pyrrolo[1,2-a][1,4,7,10,13]pentaazacyclopentadecine,cyclic peptide deriv.;
BQ 162

L-Isoleucine, L-tyrosyl-L-prolyl-L-phenylalanyl-L-valyl-L-a-glutamyl-L-prolyl-;
L-Isoleucine, N-[1-[N-[N-[N-(1-L-tyrosyl-L-prolyl)-L-phenylalanyl]-L-valyl]-L-a-glutamyl]-L-prolyl]-;
17: PN:WO2006017688 SEQID: 65 unclaimed sequence;
18: PN: WO0239997 SEQID: 23unclaimed sequence;
49: PN: WO2006068768 SEQID: 47 claimed sequence;
619: PN:US20090175821 SEQID: 745 claimed protein;
91: PN: WO0069900 SEQID: 745unclaimed sequence;
97: PN: WO0069900 SEQID: 753 unclaimed sequence;
Human b-casomorphin 7;
b-Casomorphin (human);
b-Casomorphin-7(human)

L-Threonine, L-a-glutamyl-L-isoleucyl-L-leucyl-L-a-aspartyl-L-valyl-L-prolyl-L-seryl-;
L-Threonine, N-[N-[1-[N-[N-[N-(N-L-a-glutamyl-L-isoleucyl)-L-leucyl]-L-a-aspartyl]-L-valyl]-L-prolyl]-L-seryl]-;
10: PN:WO03074722 SEQID: 10 unclaimed sequence;
13: PN: WO2005033275 SEQID: 22unclaimed sequence;
1: PN: US6376538 SEQID: 1 unclaimed sequence;
1: PN:WO0064474 PAGE: 19 unclaimed sequence;
22: PN: WO03019136 SEQID: 22 claimedsequence;
24: PN: WO0004941 PAGE: 32 claimed sequence;
35: PN: US6376248 SEQID:48 unclaimed sequence;
458: PN: WO0069900 SEQID: 1143 unclaimed sequence;
47:PN: US6051429 SEQID: 48 unclaimed sequence;
76: PN: US20030119021 SEQID: 55unclaimed sequence;
897: PN: US20090175821 SEQID: 1143 claimed protein;
8: PN:WO2008140602 SEQID: 11 unclaimed protein;
9: PN: WO2005023981 SEQID: 10unclaimed sequence

L-Tyrosine, L-valyl-L-a-glutamyl-L-prolyl-L-isoleucyl-L-prolyl-;
L-Tyrosine,N-[1-[N-[1-(N-L-valyl-L-a-glutamyl)-L-prolyl]-L-isoleucyl]-L-prolyl]-;
2: PN: CN1566152 PAGE: 4unclaimed sequence;
361: PN: WO0069900 SEQID: 1042 unclaimed sequence;
811: PN:US20090175821 SEQID: 1042 claimed protein;
99: PN: US20030119021 SEQID: 84unclaimed sequence

L-Arginine,L-tyrosyl-L-glutaminyl-L-glutaminyl-L-prolyl-L-valyl-L-leucylglycyl-L-prolyl-L-valyl-;
L-Arginine,N2-[N-[1-[N-[N-[N-[1-[N2-(N2-L-tyrosyl-L-glutaminyl)-L-glutaminyl]-L-prolyl]-L-valyl]-L-leucyl]glycyl]-L-prolyl]-L-valyl]-;
5: PN: CN1566152 PAGE: 4 unclaimed sequence;
b-Casokinin-10;
b-Casokinin-10 (ox)

L-leucine,D-tyrosyl-L-glutaminyl-L-tryptophyl-L-alanyl-L-valylglycyl-L-histidyl-, methylester (9CI);
Ranatensin,1-de(5-oxo-L-proline)-2-de-L-valine-3-D-tyrosine-10-L-leucine-11-de-L-methioninamide-,methyl ester

L-glutamine,L-isoleucyl-L-arginyl-L-prolyl-L-valyl-;
L-glutamine,N2-[N-[1-(N2-L-isoleucyl-L-arginyl)-L-prolyl]-L-valyl]-

L-Phenylalaninamide,L-valyl-L-prolyl-L-asparaginyl-L-leucyl-L-prolyl-L-glutaminyl-L-arginyl-;
NeuropeptideNPVF-amide;
Neuropeptide VF;
Rat RFRP-3

L-Tyrosine, L-a-glutamyl-L-valyl-L-a-aspartyl-L-prolyl-L-isoleucylglycyl-L-histidyl-L-leucyl-;
L-Tyrosine,N-[N-[N-[N-[N-[1-[N-(N-L-a-glutamyl-L-valyl)-L-a-aspartyl]-L-prolyl]-L-isoleucyl]glycyl]-L-histidyl]-L-leucyl]-;
10: PN:WO0049041 SEQID: 13 claimed sequence;
10: PN: WO0050589 SEQID: 10 unclaimedsequence;
10: PN: WO2008019018 SEQID: 8 unclaimed sequence;
113: PN: WO2004071457SEQID: 140 unclaimed sequence;
114: PN: US7420037 SEQID: 119 unclaimed protein;
11: PN: US6291430 SEQID: 47 unclaimed sequence;
11: PN: WO0006598 SEQID: 12unclaimed sequence;
12: PN: US6245525 SEQID: 6 unclaimed sequence;
12: PN:WO0053161 SEQID: 51 unclaimed sequence;
12: PN: WO0216560 SEQID: 44 unclaimedsequence;
12: PN: WO2004029071 SEQID: 11 claimed sequence;
1378: PN:WO2006091734 PAGE: 74 claimed sequence;
13: PN: US20040033541 SEQID: 13unclaimed sequence;
13: PN: US20090042285 SEQID: 13 claimed protein;
13: PN:US20090226474 SEQID: 13 unclaimed protein;
13: PN: WO0020445 SEQID: 3 unclaimedsequence;
13: PN: WO0050077 SEQID: 13 claimed sequence;
13: PN: WO0129220SEQID: 11 unclaimed sequence;
141: PN: WO

L-Alanine,L-tyrosyl-L-leucyl-L-a-glutamyl-L-prolylglycyl-L-prolyl-L-valyl-L-threonyl-;
L-Alanine,N-[N-[N-[1-[N-[1-[N-(N-L-tyrosyl-L-leucyl)-L-a-glutamyl]-L-prolyl]glycyl]-L-prolyl]-L-valyl]-L-threonyl]-;
10: PN: US6312684 SEQID: 10 claimed sequence;
115: PN: WO2004071457 SEQID: 142unclaimed sequence;
116: PN: US7420037 SEQID: 121 unclaimed protein;
1262: PN:WO2006091734 PAGE: 71 claimed sequence;
13: PN: WO03024480 PAGE: 84 unclaimedsequence;
15: PN: WO03047506 SEQID: 15 unclaimed sequence;
16: PN: WO2005004907SEQID: 16 unclaimed sequence;
18: PN: US6660276 SEQID: 14 claimed sequence;
18:PN: WO2004102198 SEQID: 44 claimed sequence;
18: PN: WO2008019018 SEQID: 16unclaimed sequence;
19: PN: US20070048860 SEQID: 3 unclaimed sequence;
19: PN:WO2008120202 SEQID: 5 claimed sequence;
1: PN: US20060188469 SEQID: 14unclaimed sequence;
1: PN: WO0009145 SEQID: 10 unclaimed sequence;
1: PN:WO2009013018 SEQID: 1 claimed sequence;
24: PN: WO0200914 SEQID: 25 unclaimedsequence;
24: PN: WO2008054611 TABLE: 2 unclaimed sequence;
251: PN:WO2009109428 SEQID: 255 claimed protein;
26: PN: WO0

TYR-glu-val-HIS-HIS-GLN-LYS-leu-val-PHE-PHE

H-TYR-glu-val-HIS-HIS-GLN-LYS-leu-val-PHE-PHE-OH;
AMYLOID BETA-proTEIN (10-20);
AMYLOID BETA-PEPTIDE (10-20) (HUMAN);
AMYLOID BETA-proTEIN FRAGMENT 10-20;
H-TYR-glu-val-HIS-HIS-GLN-LYS-leu-val-PHE-PHE-OH;
BETA-AMYLOID (10-20);
YEVHHQKLVFF;
TYR-glu-val-HIS-HIS-GLN-LYS-leu-val-PHE-PHE;
amyloid B-protein fragment 10-20

H-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-OH

H-ASP-ALA-glu-PHE-ARG-HIS-ASP-SER-GLY-TYR-glu-val-HIS-HIS-GLN-LYS-leu-val-PHE-PHE-ALA-glu-ASP-val-GL;
PREDOMINANT AMYLOID B-proTEIN FRAGMENT;
ASP-ALA-glu-PHE-ARG-HIS-ASP-SER-GLY-TYR-glu-val-HIS-HIS-GLN-LYS-leu-val-PHE-PHE-ALA-glu-ASP-val-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-leu-MET-val-GLY-GLY-val-val-ILE-ALA;
ASP-ALA-glu-PHE-GLY-HIS-ASP-SER-GLY-PHE-glu-val-ARG-HIS-GLN-LYS-leu-val-PHE-PHE-ALA-glu-ASP-val-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-leu-MET-val-GLY-GLY-val-val-ILE-ALA;
BAP 1-42;
BETA-AMYLOID, SODIUM SALT;
BETA-AMYLOID PEPTIDE (1-40), MOUSE, RAT;
BETA-AMYLOID PEPTIDE (1-40), RAT;
BETA-AMYLOID PEPTIDE (1-42), RAT

無

神經(jīng)儲(chǔ)鈣蛋白基質(zhì)

ASP-leu-ASP-val-pro-ILE-pro-GLY-ARG-PHE-ASP-ARG-ARG-val-SER-val-ALA-ALA-glu;
ASP-leu-ASP-val-pro-ILE-pro-GLY-ARG-PHE-ASP-ARG-ARG-val-SER-val-ALA-ALA-glu;
DLDVPIPGRFDRRVSVAAE;
CALCINEURIN (PP2B) SUBSTRATE [DLDVPIPGRFDRRVSSVAAE], NON-PHOSPHORYLATED;
CALCINEURIN SUBSTRATE;
H-ASP-leu-ASP-val-pro-ILE-pro-GLY-ARG-PHE-ASP-ARG-ARG-val-SER-val-ALA-ALA-glu-OH;
[ALA-97]-RII (81-99);
Calcineurin (PP2B) Substrate [DLDVPIPGRFDRRVSVAAE], Non-Phosphorylated

(DES-OCTANOYL)-GHRELIN (HUMAN)

H-GLY-SER-SER-PHE-leu-SER-pro-glu-HIS-GLN-ARG-val-GLN-GLN-ARG-LYS-glu-SER-LYS-LYS-pro-pro-ALA-LYS-LE;
GSSFLSPEHQRVQQRKESKKPPAKLQPR;
GLY-SER-SER-PHE-leu-SER-pro-glu-HIS-GLN-ARG-val-GLN-GLN-ARG-LYS-glu-SER-LYS-LYS-pro-pro-ALA-LYS-leu-GLN-pro-ARG;
H-GLY-SER-SER-PHE-leu-SER-pro-glu-HIS-GLN-ARG-val-GLN-GLN-ARG-LYS-glu-SER-LYS-LYS-pro-pro-ALA-LYS-leu-GLN-pro-ARG-OH;
(DES-OCTANOYL)-GHRELIN (HUMAN);
H-Gly-Ser-Ser-Phe-leu-Ser-pro-glu-His-Gln-Arg-val-Gln-Gln-Arg-Lys-glu-Ser-Lys-Lys-pro-pro-Ala-Lys-leu-Gln-pro-Arg-OH;
M.W. 3244.51 C141H235N47O41

EGF RECEPTOR (985-996) (HUMAN)

ASP-val-val-ASP-ALA-ASP-glu-TYR-leu-ILE-pro-GLN;
EPIDERMAL GROWTH FACTOR RECEPTOR (985-996) (HUMAN);
EPIDERMAL GROWTH FACTOR RECEPTOR PEPTIDE (985-996);
EPIDERMAL GROWTH FACTOR RECEPTOR PEPTIDE (985-996) (HUMAN);
EPIDERMAL GROWTH FACTOR RECEPTOR PEPTIDE (HUMAN);
EGF RECEPTOR (985-996) (HUMAN);
EGF RECEPTOR PEPTIDE (985-996) (HUMAN);
H-ASP-val-val-ASP-ALA-ASP-glu-TYR-leu-ILE-pro-GLN-OH;
ASP-val-val-ASP-ALA-ASP-glu-TYR-leu-ILE-pro-GLN

髓鞘少突膠質(zhì)細(xì)胞糖蛋白

H-MET-glu-val-GLY-TRP-TYR-ARG-SER-pro-PHE-SER-ARG-val-val-HIS-leu-TYR-ARG-ASN-GLY-LYS-OH;
H-MET-glu-val-GLY-TRP-TYR-ARG-SER-pro-PHE-SER-ARG-val-val-HIS-leu-TYR-ARG-ASN-GLY-LYS-OH;
H-MET-glu-val-GLY-TRP-TYR-ARG-SER-pro-PHE-SER-ARG-val-val-HIS-leu-TYR-ARG-ASN-GLY-LYS-OH (MOUSE, RAT);
MET-glu-val-GLY-TRP-TYR-ARG-SER-pro-PHE-SER-ARG-val-val-HIS-leu-TYR-ARG-ASN-GLY-LYS;
MEVGWYRSPFSRVVHLYRNGK;
MYELIN OLIGODENDROCYTE GLYCOproTEIN PEPTIDE (35-55) (RAT, MOUSE);
MYELIN OLIGODENDROCYTE GLYCOproTEIN PEPTIDE FRAGMENT 35-55 RAT, MOUSE;
MYELIN OLIGODENDROCYTE GLYCOproTEIN (35-55) (MOUSE, RAT);
MYELIN OLIGODENDROCYTE GLYCOproTEIN (35-55), RAT

GLY-ALA-pro-val-pro-TYR-pro-ASP-pro-leu-glu-pro-ARG

GLY-ALA-pro-val-pro-TYR-pro-ASP-pro-leu-glu-pro-ARG;
OSTEOCALCIN (7-19) (HUMAN);
OSTEOCALCIN, FRAGMENT 7-19;
OSTEOCALCIN FRAGMENT 7-19 HUMAN;
GLY-ALA-pro-val-pro-TYR-pro-ASP-pro-leu-glu-pro-ARG;
GAPVPYPDPLEPR;
[glu17]-OSTEOCALCIN (7-19) (HUMAN);
H-GLY-ALA-pro-val-pro-TYR-pro-ASP-pro-leu-glu-pro-ARG-OH

人體胰臟多肽

PANCREATIC POLYPEPTIDE, HUMAN;
H-ALA-pro-leu-glu-pro-val-TYR-pro-GLY-ASP-ASN-ALA-THR-pro-glu-GLN-MET-ALA-GLN-TYR-ALA-ALA-ASP-leu-ARG-ARG-TYR-ILE-ASN-MET-leu-THR-ARG-pro-ARG-TYR-NH2;
APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2;
ALA-pro-leu-glu-pro-val-TYR-pro-GLY-ASP-ASN-ALA-THR-pro-glu-GLN-MET-ALA-GLN-MET-ALA-GLN-TYR-ALA-ALA-ASP-leu-ARG-ARG-TYR-ILE-ASN-MET-leu-THR-ARG-pro-ARG-TYR-NH2;
ALA-pro-leu-glu-pro-val-TYR-pro-GLY-ASP-ASN-ALA-THR-pro-glu-GLN-MET-ALA-GLN-TYR-ALA-ALA-ASP-leu-ARG-ARG-TYR-ILE-ASN-MET-leu-THR-ARG-pro-ARG-TYR-NH2;
ALA-pro-leu-glu-pro-val-TYR-pro-GLY-ASP-ASN-ALA-THR-pro-glu-GLN-MET-ALA-GLN-TYR-ALA-ALA-ASP-leu-ARG-ARG-TYR-ILE-ASN-MET-leu-THR-ARG-pro-ARG-TYR-NH2 HUMAN;
PP, HUMAN;
PANCREATIC POLYPEPTIDE;
PANCREATIC POLYPEPTIDE, HUMAN

淀粉Β-蛋白(22-35);
淀粉Β-蛋白(22-35);
H-EDVLGSNKGAIIGLM-OH

H-glu-ASP-val-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-leu-MET-OH;
AMYLOID BETA-proTEIN FRAGMENT 22-35;
AMYLOID BETA-proTEIN (22-35);
EDVGSNKGAIIGLM;
H-glu-ASP-val-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-leu-MET-OH;
glu-ASP-val-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-leu-MET;
BETA-AMYLOID (22-35);
AMYLOID B-proTEIN FRAGMENT 22-35;
amyloid β-protein fragment 22-35

ASP-ALA-glu-ASN-leu-ILE-ASP-SER-PHE-GLN-glu-ILE-val;
ASP-ALA-glu-ASN-leu-ILE-ASP-SER-PHE-GLN-glu-ILE-

ASP-ALA-glu-ASN-leu-ILE-ASP-SER-PHE-GLN-glu-ILE-val;
PREpro HUMAN GNRH PRECURSOR PEPTIDE (14-26);
ASP-ALA-glu-ASN-leu-ILE-ASP-SER-PHE-GLN-glu-ILE-val;
H-ASP-ALA-glu-ASN-leu-ILE-ASP-SER-PHE-GLN-glu-ILE-val-OH;
GNRH PRECURSOR (14-26), RAT;
GNRH PRECURSOR PEPTIDE (14-26) (HUMAN);
GNRH ASSOCIATED PEPTIDE (1-13), HUMAN;
GONADOTROPIN RELEASING HORMONE ASSOCIATED PEPTIDE (1-13) (HUMAN);
HUMAN PRE-pro-GONADOTROPIN RELEASING HORMONE FRAGMENT 14-26

C65H101N15O25

詳情

供應(yīng)商

化工產(chǎn)品